Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

TEKMIRA HALTED

Sam RoAug 8, 2014, 01:35 IST

Tekmira Pharmaceuticals has been halted for trading pending news.

The $300 million biotech firm has received lots of attention recently due to its unapproved drug TKM-Ebola, a treatment for the deadly virus ravaging people in West Africa.

"Earlier this month, the [U.S. Food and Drug Administration] put a hold on a Tekmira Pharmaceuticals Corp clinical trial of TKM-Ebola, one of the few Ebola treatments advanced enough to be tested in people," reported Reuters' Julie Steenhuysen.

The stock has been trading in a wide range in recent weeks, swinging between $5.08 and $31.48 in the past year.

Shares closed at $14.23, up 6.5% for the day.

More to come...